Insilico Medicine presents at Future Investment Initiative Conference in Riyadh
Executives from clinical stage artificial intelligence (AI)-driven drug discovery company Insilico Medicine will present on the impact of AI on biotechnology at the Future Investment Initiative (FII) Conference in Riyadh, Saudi Arabia.
Alex Zhavoronkov, PhD, founder and CEO of Insilico Medicine and Petrina Kamya, PhD, Head of AI Platforms and President of Insilico Medicine Canada will present on the topic “Will AI Rebuild Biotech?” on Oct. 26, 11:45am Arabic Standard Time. The event is available to be livestreamed.
The FII Conference brings together the world’s foremost CEOs, policymakers, ...








